nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—Thalidomide—leprosy	0.252	0.301	CbGbCtD
Hydromorphone—PTGS1—Dapsone—leprosy	0.201	0.24	CbGbCtD
Hydromorphone—CYP2C9—Thalidomide—leprosy	0.101	0.121	CbGbCtD
Hydromorphone—CYP2C9—Rifampicin—leprosy	0.0982	0.117	CbGbCtD
Hydromorphone—CYP2C9—Dapsone—leprosy	0.0811	0.0967	CbGbCtD
Hydromorphone—CYP3A4—Rifampicin—leprosy	0.0571	0.0681	CbGbCtD
Hydromorphone—CYP3A4—Dapsone—leprosy	0.0472	0.0562	CbGbCtD
Hydromorphone—Application site pain—Dapsone—leprosy	0.00639	0.0396	CcSEcCtD
Hydromorphone—Hangover—Thalidomide—leprosy	0.0061	0.0378	CcSEcCtD
Hydromorphone—Hyporeflexia—Thalidomide—leprosy	0.00317	0.0196	CcSEcCtD
Hydromorphone—Altered state of consciousness—Thalidomide—leprosy	0.00312	0.0193	CcSEcCtD
Hydromorphone—Sexual dysfunction—Thalidomide—leprosy	0.00257	0.0159	CcSEcCtD
Hydromorphone—Myasthenia—Thalidomide—leprosy	0.00229	0.0142	CcSEcCtD
Hydromorphone—Intestinal obstruction—Thalidomide—leprosy	0.00211	0.0131	CcSEcCtD
Hydromorphone—Menstrual disorder—Thalidomide—leprosy	0.00211	0.0131	CcSEcCtD
Hydromorphone—Hypercalcaemia—Thalidomide—leprosy	0.00207	0.0128	CcSEcCtD
Hydromorphone—Lung disorder—Thalidomide—leprosy	0.00203	0.0126	CcSEcCtD
Hydromorphone—Hepatomegaly—Thalidomide—leprosy	0.00203	0.0126	CcSEcCtD
Hydromorphone—Cyanosis—Thalidomide—leprosy	0.00203	0.0126	CcSEcCtD
Hydromorphone—Nystagmus—Thalidomide—leprosy	0.00201	0.0125	CcSEcCtD
Hydromorphone—Psychotic disorder—Dapsone—leprosy	0.00199	0.0123	CcSEcCtD
Hydromorphone—Stupor—Thalidomide—leprosy	0.00193	0.0119	CcSEcCtD
Hydromorphone—Hyperaesthesia—Thalidomide—leprosy	0.00183	0.0114	CcSEcCtD
Hydromorphone—Nasopharyngitis—Dapsone—leprosy	0.00182	0.0113	CcSEcCtD
Hydromorphone—Muscular weakness—Dapsone—leprosy	0.0018	0.0111	CcSEcCtD
Hydromorphone—Endocrine disorder—Thalidomide—leprosy	0.00174	0.0107	CcSEcCtD
Hydromorphone—Apnoea—Thalidomide—leprosy	0.0017	0.0105	CcSEcCtD
Hydromorphone—Accidental injury—Thalidomide—leprosy	0.00163	0.0101	CcSEcCtD
Hydromorphone—Arthropathy—Thalidomide—leprosy	0.00158	0.0098	CcSEcCtD
Hydromorphone—Oliguria—Thalidomide—leprosy	0.00156	0.00967	CcSEcCtD
Hydromorphone—Drug interaction—Thalidomide—leprosy	0.00155	0.00961	CcSEcCtD
Hydromorphone—Hyperuricaemia—Thalidomide—leprosy	0.00155	0.00961	CcSEcCtD
Hydromorphone—Dyskinesia—Thalidomide—leprosy	0.00153	0.00948	CcSEcCtD
Hydromorphone—Gait disturbance—Thalidomide—leprosy	0.00147	0.00913	CcSEcCtD
Hydromorphone—Blood uric acid increased—Thalidomide—leprosy	0.00146	0.00907	CcSEcCtD
Hydromorphone—Coordination abnormal—Thalidomide—leprosy	0.00146	0.00907	CcSEcCtD
Hydromorphone—Eructation—Thalidomide—leprosy	0.00141	0.00875	CcSEcCtD
Hydromorphone—Depressed level of consciousness—Thalidomide—leprosy	0.00139	0.0086	CcSEcCtD
Hydromorphone—Dry eye—Thalidomide—leprosy	0.00133	0.00823	CcSEcCtD
Hydromorphone—Cramps of lower extremities—Thalidomide—leprosy	0.00132	0.00819	CcSEcCtD
Hydromorphone—Tinnitus—Dapsone—leprosy	0.00132	0.00815	CcSEcCtD
Hydromorphone—Lightheadedness—Thalidomide—leprosy	0.00129	0.00797	CcSEcCtD
Hydromorphone—Pulmonary oedema—Thalidomide—leprosy	0.00128	0.00793	CcSEcCtD
Hydromorphone—Euphoric mood—Thalidomide—leprosy	0.00124	0.00766	CcSEcCtD
Hydromorphone—Erythema—Dapsone—leprosy	0.00123	0.00761	CcSEcCtD
Hydromorphone—Gastroenteritis—Thalidomide—leprosy	0.00118	0.0073	CcSEcCtD
Hydromorphone—Vision blurred—Dapsone—leprosy	0.00116	0.00717	CcSEcCtD
Hydromorphone—Injury—Thalidomide—leprosy	0.00114	0.00704	CcSEcCtD
Hydromorphone—Libido decreased—Thalidomide—leprosy	0.00113	0.00697	CcSEcCtD
Hydromorphone—Increased appetite—Thalidomide—leprosy	0.00111	0.00688	CcSEcCtD
Hydromorphone—Amnesia—Thalidomide—leprosy	0.00111	0.00688	CcSEcCtD
Hydromorphone—Vertigo—Dapsone—leprosy	0.0011	0.00684	CcSEcCtD
Hydromorphone—Visual disturbance—Thalidomide—leprosy	0.0011	0.00683	CcSEcCtD
Hydromorphone—Cough—Dapsone—leprosy	0.00107	0.00664	CcSEcCtD
Hydromorphone—Lethargy—Thalidomide—leprosy	0.00107	0.0066	CcSEcCtD
Hydromorphone—Hyponatraemia—Thalidomide—leprosy	0.00105	0.00649	CcSEcCtD
Hydromorphone—Diplopia—Thalidomide—leprosy	0.00104	0.00647	CcSEcCtD
Hydromorphone—Osteoarthritis—Thalidomide—leprosy	0.00104	0.00647	CcSEcCtD
Hydromorphone—Pain in extremity—Thalidomide—leprosy	0.00104	0.00647	CcSEcCtD
Hydromorphone—Disturbance in sexual arousal—Thalidomide—leprosy	0.00104	0.00642	CcSEcCtD
Hydromorphone—Migraine—Thalidomide—leprosy	0.00103	0.00637	CcSEcCtD
Hydromorphone—Affect lability—Thalidomide—leprosy	0.00103	0.00637	CcSEcCtD
Hydromorphone—Psychotic disorder—Thalidomide—leprosy	0.00102	0.00632	CcSEcCtD
Hydromorphone—Cardiac arrest—Thalidomide—leprosy	0.000993	0.00615	CcSEcCtD
Hydromorphone—Mood swings—Thalidomide—leprosy	0.000989	0.00613	CcSEcCtD
Hydromorphone—Tachycardia—Dapsone—leprosy	0.000978	0.00606	CcSEcCtD
Hydromorphone—Dehydration—Thalidomide—leprosy	0.000971	0.00602	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Thalidomide—leprosy	0.000954	0.00591	CcSEcCtD
Hydromorphone—Breast disorder—Thalidomide—leprosy	0.000944	0.00584	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00094	0.00582	CcSEcCtD
Hydromorphone—Cramp muscle—Thalidomide—leprosy	0.00094	0.00582	CcSEcCtD
Hydromorphone—Muscular weakness—Thalidomide—leprosy	0.000921	0.0057	CcSEcCtD
Hydromorphone—Abdominal distension—Thalidomide—leprosy	0.000909	0.00563	CcSEcCtD
Hydromorphone—Insomnia—Dapsone—leprosy	0.000907	0.00562	CcSEcCtD
Hydromorphone—Dysphagia—Thalidomide—leprosy	0.000902	0.00559	CcSEcCtD
Hydromorphone—Bronchospasm—Thalidomide—leprosy	0.000888	0.0055	CcSEcCtD
Hydromorphone—Pollakiuria—Thalidomide—leprosy	0.000834	0.00516	CcSEcCtD
Hydromorphone—Erectile dysfunction—Thalidomide—leprosy	0.000831	0.00515	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Dapsone—leprosy	0.00082	0.00508	CcSEcCtD
Hydromorphone—Weight decreased—Thalidomide—leprosy	0.000816	0.00506	CcSEcCtD
Hydromorphone—Infestation—Thalidomide—leprosy	0.000805	0.00498	CcSEcCtD
Hydromorphone—Drowsiness—Thalidomide—leprosy	0.000805	0.00498	CcSEcCtD
Hydromorphone—Infestation NOS—Thalidomide—leprosy	0.000805	0.00498	CcSEcCtD
Hydromorphone—Depression—Thalidomide—leprosy	0.000802	0.00497	CcSEcCtD
Hydromorphone—Body temperature increased—Dapsone—leprosy	0.000792	0.00491	CcSEcCtD
Hydromorphone—Abdominal pain—Dapsone—leprosy	0.000792	0.00491	CcSEcCtD
Hydromorphone—Stomatitis—Thalidomide—leprosy	0.000784	0.00486	CcSEcCtD
Hydromorphone—Sweating—Thalidomide—leprosy	0.000771	0.00478	CcSEcCtD
Hydromorphone—Bradycardia—Thalidomide—leprosy	0.000735	0.00456	CcSEcCtD
Hydromorphone—Rhinitis—Thalidomide—leprosy	0.000724	0.00449	CcSEcCtD
Hydromorphone—Hypoaesthesia—Thalidomide—leprosy	0.000719	0.00445	CcSEcCtD
Hydromorphone—Urinary tract disorder—Thalidomide—leprosy	0.000713	0.00442	CcSEcCtD
Hydromorphone—Oedema peripheral—Thalidomide—leprosy	0.000712	0.00441	CcSEcCtD
Hydromorphone—Urethral disorder—Thalidomide—leprosy	0.000708	0.00439	CcSEcCtD
Hydromorphone—Visual impairment—Thalidomide—leprosy	0.000696	0.00431	CcSEcCtD
Hydromorphone—Eye disorder—Thalidomide—leprosy	0.000675	0.00418	CcSEcCtD
Hydromorphone—Tinnitus—Thalidomide—leprosy	0.000673	0.00417	CcSEcCtD
Hydromorphone—Cardiac disorder—Thalidomide—leprosy	0.00067	0.00415	CcSEcCtD
Hydromorphone—Angiopathy—Thalidomide—leprosy	0.000655	0.00406	CcSEcCtD
Hydromorphone—Immune system disorder—Thalidomide—leprosy	0.000652	0.00404	CcSEcCtD
Hydromorphone—Mediastinal disorder—Thalidomide—leprosy	0.000651	0.00403	CcSEcCtD
Hydromorphone—Chills—Thalidomide—leprosy	0.000648	0.00401	CcSEcCtD
Hydromorphone—Arrhythmia—Thalidomide—leprosy	0.000645	0.004	CcSEcCtD
Hydromorphone—Vomiting—Dapsone—leprosy	0.000637	0.00395	CcSEcCtD
Hydromorphone—Mental disorder—Thalidomide—leprosy	0.000633	0.00392	CcSEcCtD
Hydromorphone—Malnutrition—Thalidomide—leprosy	0.000629	0.0039	CcSEcCtD
Hydromorphone—Headache—Dapsone—leprosy	0.000628	0.00389	CcSEcCtD
Hydromorphone—Flatulence—Thalidomide—leprosy	0.00062	0.00384	CcSEcCtD
Hydromorphone—Tension—Thalidomide—leprosy	0.000617	0.00382	CcSEcCtD
Hydromorphone—Dysgeusia—Thalidomide—leprosy	0.000616	0.00381	CcSEcCtD
Hydromorphone—Nervousness—Thalidomide—leprosy	0.000611	0.00378	CcSEcCtD
Hydromorphone—Back pain—Thalidomide—leprosy	0.000608	0.00377	CcSEcCtD
Hydromorphone—Muscle spasms—Thalidomide—leprosy	0.000605	0.00374	CcSEcCtD
Hydromorphone—Nausea—Dapsone—leprosy	0.000595	0.00369	CcSEcCtD
Hydromorphone—Vision blurred—Thalidomide—leprosy	0.000593	0.00367	CcSEcCtD
Hydromorphone—Tremor—Thalidomide—leprosy	0.000589	0.00365	CcSEcCtD
Hydromorphone—Ill-defined disorder—Thalidomide—leprosy	0.000583	0.00361	CcSEcCtD
Hydromorphone—Agitation—Thalidomide—leprosy	0.000578	0.00358	CcSEcCtD
Hydromorphone—Angioedema—Thalidomide—leprosy	0.000575	0.00356	CcSEcCtD
Hydromorphone—Malaise—Thalidomide—leprosy	0.000567	0.00351	CcSEcCtD
Hydromorphone—Vertigo—Thalidomide—leprosy	0.000565	0.0035	CcSEcCtD
Hydromorphone—Syncope—Thalidomide—leprosy	0.000564	0.00349	CcSEcCtD
Hydromorphone—Leukopenia—Thalidomide—leprosy	0.000563	0.00349	CcSEcCtD
Hydromorphone—Palpitations—Thalidomide—leprosy	0.000556	0.00344	CcSEcCtD
Hydromorphone—Loss of consciousness—Thalidomide—leprosy	0.000553	0.00342	CcSEcCtD
Hydromorphone—Cough—Thalidomide—leprosy	0.000549	0.0034	CcSEcCtD
Hydromorphone—Convulsion—Thalidomide—leprosy	0.000545	0.00337	CcSEcCtD
Hydromorphone—Hypertension—Thalidomide—leprosy	0.000543	0.00336	CcSEcCtD
Hydromorphone—Chest pain—Thalidomide—leprosy	0.000535	0.00332	CcSEcCtD
Hydromorphone—Myalgia—Thalidomide—leprosy	0.000535	0.00332	CcSEcCtD
Hydromorphone—Arthralgia—Thalidomide—leprosy	0.000535	0.00332	CcSEcCtD
Hydromorphone—Anxiety—Thalidomide—leprosy	0.000533	0.0033	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000532	0.00329	CcSEcCtD
Hydromorphone—Discomfort—Thalidomide—leprosy	0.000529	0.00328	CcSEcCtD
Hydromorphone—Dry mouth—Thalidomide—leprosy	0.000524	0.00324	CcSEcCtD
Hydromorphone—Confusional state—Thalidomide—leprosy	0.000517	0.00321	CcSEcCtD
Hydromorphone—Infection—Thalidomide—leprosy	0.00051	0.00316	CcSEcCtD
Hydromorphone—Shock—Thalidomide—leprosy	0.000505	0.00313	CcSEcCtD
Hydromorphone—Nervous system disorder—Thalidomide—leprosy	0.000503	0.00312	CcSEcCtD
Hydromorphone—Tachycardia—Thalidomide—leprosy	0.000501	0.0031	CcSEcCtD
Hydromorphone—Skin disorder—Thalidomide—leprosy	0.000498	0.00309	CcSEcCtD
Hydromorphone—Hyperhidrosis—Thalidomide—leprosy	0.000496	0.00307	CcSEcCtD
Hydromorphone—Anorexia—Thalidomide—leprosy	0.000489	0.00303	CcSEcCtD
Hydromorphone—Hypotension—Thalidomide—leprosy	0.00048	0.00297	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000468	0.0029	CcSEcCtD
Hydromorphone—Insomnia—Thalidomide—leprosy	0.000464	0.00288	CcSEcCtD
Hydromorphone—Paraesthesia—Thalidomide—leprosy	0.000461	0.00285	CcSEcCtD
Hydromorphone—Dyspnoea—Thalidomide—leprosy	0.000458	0.00283	CcSEcCtD
Hydromorphone—Somnolence—Thalidomide—leprosy	0.000456	0.00283	CcSEcCtD
Hydromorphone—Dyspepsia—Thalidomide—leprosy	0.000452	0.0028	CcSEcCtD
Hydromorphone—Decreased appetite—Thalidomide—leprosy	0.000446	0.00276	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Thalidomide—leprosy	0.000443	0.00274	CcSEcCtD
Hydromorphone—Fatigue—Thalidomide—leprosy	0.000442	0.00274	CcSEcCtD
Hydromorphone—Constipation—Thalidomide—leprosy	0.000439	0.00272	CcSEcCtD
Hydromorphone—Pain—Thalidomide—leprosy	0.000439	0.00272	CcSEcCtD
Hydromorphone—Feeling abnormal—Thalidomide—leprosy	0.000423	0.00262	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Thalidomide—leprosy	0.00042	0.0026	CcSEcCtD
Hydromorphone—Urticaria—Thalidomide—leprosy	0.000408	0.00253	CcSEcCtD
Hydromorphone—Abdominal pain—Thalidomide—leprosy	0.000406	0.00251	CcSEcCtD
Hydromorphone—Body temperature increased—Thalidomide—leprosy	0.000406	0.00251	CcSEcCtD
Hydromorphone—Hypersensitivity—Thalidomide—leprosy	0.000378	0.00234	CcSEcCtD
Hydromorphone—Asthenia—Thalidomide—leprosy	0.000368	0.00228	CcSEcCtD
Hydromorphone—Pruritus—Thalidomide—leprosy	0.000363	0.00225	CcSEcCtD
Hydromorphone—Diarrhoea—Thalidomide—leprosy	0.000351	0.00218	CcSEcCtD
Hydromorphone—Dizziness—Thalidomide—leprosy	0.000339	0.0021	CcSEcCtD
Hydromorphone—Vomiting—Thalidomide—leprosy	0.000326	0.00202	CcSEcCtD
Hydromorphone—Rash—Thalidomide—leprosy	0.000324	0.002	CcSEcCtD
Hydromorphone—Dermatitis—Thalidomide—leprosy	0.000323	0.002	CcSEcCtD
Hydromorphone—Headache—Thalidomide—leprosy	0.000321	0.00199	CcSEcCtD
Hydromorphone—Nausea—Thalidomide—leprosy	0.000305	0.00189	CcSEcCtD
